source
- Iambic Therapeutics raises $150 million in IPO to fund oncology drug developmentIambic Therapeutics, a San Diego-based AI biotech, completed an initial public offering that raised $150 million, exactly meeting its goal of selling 9.4 million shares at $16 each. The company sa…
- Experts call for dedicated regulatory framework for clinical AI models, UK MHRA unveils AI-focused strategyFormer FDA commissioner Scott Gottlieb, now at the American Enterprise Institute, wrote an opinion piece urging Congress to create a specific regulatory framework for artificial intelligence models…